Ethicon Official In Pa. Mesh Trial Defends Product's Safety
Law360, Philadelphia (December 7, 2015, 6:07 PM EST) -- A top engineer with a Johnson & Johnson subsidiary told a Philadelphia jury on Monday that safety concerns over a pelvic mesh implant blamed for untreatable injuries in an Indiana woman had been rigorously vetted before the product went to market in 2005.
After facing questions from a plaintiff's attorney on Friday, Ethicon Inc. research and development director Scott Ciarrocca testified that company officials and the product's developers had properly concluded that the Prolift pelvic mesh implant was a safe and effective way of treating organ prolapse in women.
"We felt that the benefits outweighed the risks," he said. "I think...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!